D-Pinitol mitigates post-traumatic stress disorder-like behaviors induced by single prolonged stress in mice through mineralocorticoid receptor antagonism
Copyright © 2024 Elsevier Inc. All rights reserved..
Post-traumatic stress disorder (PTSD) is a mental illness that can occur in individuals who have experienced trauma. Current treatments for PTSD, typically serotonin reuptake inhibitors, have limited effectiveness for patients and often cause serious adverse effects. Therefore, a novel class of treatment with better pharmacological profile is necessary. D-Pinitol has been reported to be effective for depression and anxiety disorders, but there are no reports associated with PTSD. In the present study, we investigated the effects of D-pinitol in a mouse model of PTSD induced by a single prolonged stress (SPS) protocol. We examined the therapeutic effects of D-pinitol on emotional and cognitive impairments in the SPS mouse model. We also investigated the effects of D-pinitol on fear memory formation. Mineralocorticoid receptor transactivation assay, Western blot, and quantitative PCR were employed to investigate how D-pinitol exerts its pharmacological activities. D-Pinitol ameliorated PTSD-like behaviors in a SPS mouse model. D-Pinitol also normalized the increased mRNA expression levels and protein levels of the mineralocorticoid receptor in the amygdala. A mineralocorticoid receptor agonist reversed the effects of D-pinitol on fear extinction and recall, and the antagonistic property of D-pinitol against the mineralocorticoid receptor was confirmed in vitro. Our findings suggest that D-pinitol could serve as a potential therapeutic agent for PTSD due to its antagonistic effect on the mineralocorticoid receptor.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:132 |
---|---|
Enthalten in: |
Progress in neuro-psychopharmacology & biological psychiatry - 132(2024) vom: 08. Apr., Seite 110990 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kong, Chang Hyeon [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 15.04.2024 Date Revised 15.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.pnpbp.2024.110990 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369570545 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369570545 | ||
003 | DE-627 | ||
005 | 20240415233400.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240312s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.pnpbp.2024.110990 |2 doi | |
028 | 5 | 2 | |a pubmed24n1376.xml |
035 | |a (DE-627)NLM369570545 | ||
035 | |a (NLM)38467326 | ||
035 | |a (PII)S0278-5846(24)00058-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kong, Chang Hyeon |e verfasserin |4 aut | |
245 | 1 | 0 | |a D-Pinitol mitigates post-traumatic stress disorder-like behaviors induced by single prolonged stress in mice through mineralocorticoid receptor antagonism |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.04.2024 | ||
500 | |a Date Revised 15.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier Inc. All rights reserved. | ||
520 | |a Post-traumatic stress disorder (PTSD) is a mental illness that can occur in individuals who have experienced trauma. Current treatments for PTSD, typically serotonin reuptake inhibitors, have limited effectiveness for patients and often cause serious adverse effects. Therefore, a novel class of treatment with better pharmacological profile is necessary. D-Pinitol has been reported to be effective for depression and anxiety disorders, but there are no reports associated with PTSD. In the present study, we investigated the effects of D-pinitol in a mouse model of PTSD induced by a single prolonged stress (SPS) protocol. We examined the therapeutic effects of D-pinitol on emotional and cognitive impairments in the SPS mouse model. We also investigated the effects of D-pinitol on fear memory formation. Mineralocorticoid receptor transactivation assay, Western blot, and quantitative PCR were employed to investigate how D-pinitol exerts its pharmacological activities. D-Pinitol ameliorated PTSD-like behaviors in a SPS mouse model. D-Pinitol also normalized the increased mRNA expression levels and protein levels of the mineralocorticoid receptor in the amygdala. A mineralocorticoid receptor agonist reversed the effects of D-pinitol on fear extinction and recall, and the antagonistic property of D-pinitol against the mineralocorticoid receptor was confirmed in vitro. Our findings suggest that D-pinitol could serve as a potential therapeutic agent for PTSD due to its antagonistic effect on the mineralocorticoid receptor | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Amygdala | |
650 | 4 | |a D-Pinitol | |
650 | 4 | |a Glucocorticoid receptor | |
650 | 4 | |a Mineralocorticoid receptor | |
650 | 4 | |a Post-traumatic stress disorder | |
650 | 4 | |a Single prolonged stress | |
650 | 7 | |a pinitol |2 NLM | |
650 | 7 | |a 484-68-4 |2 NLM | |
650 | 7 | |a Receptors, Mineralocorticoid |2 NLM | |
650 | 7 | |a Inositol |2 NLM | |
650 | 7 | |a 4L6452S749 |2 NLM | |
700 | 1 | |a Lee, Jin Woo |e verfasserin |4 aut | |
700 | 1 | |a Jeon, Mijin |e verfasserin |4 aut | |
700 | 1 | |a Kang, Woo Chang |e verfasserin |4 aut | |
700 | 1 | |a Kim, Min Seo |e verfasserin |4 aut | |
700 | 1 | |a Park, Keontae |e verfasserin |4 aut | |
700 | 1 | |a Bae, Ho Jung |e verfasserin |4 aut | |
700 | 1 | |a Park, Se Jin |e verfasserin |4 aut | |
700 | 1 | |a Jung, Seo Yun |e verfasserin |4 aut | |
700 | 1 | |a Kim, Su-Nam |e verfasserin |4 aut | |
700 | 1 | |a Kleinfelter, Benjamin |e verfasserin |4 aut | |
700 | 1 | |a Kim, Ji-Woon |e verfasserin |4 aut | |
700 | 1 | |a Ryu, Jong Hoon |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Progress in neuro-psychopharmacology & biological psychiatry |d 1985 |g 132(2024) vom: 08. Apr., Seite 110990 |w (DE-627)NLM012970751 |x 1878-4216 |7 nnns |
773 | 1 | 8 | |g volume:132 |g year:2024 |g day:08 |g month:04 |g pages:110990 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pnpbp.2024.110990 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 132 |j 2024 |b 08 |c 04 |h 110990 |